Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis. [PDF]
Yi Z +4 more
europepmc +1 more source
Burden of Pneumococcal Disease and Adult Vaccination Landscape: An Overview with Data and Policy Insights from Türkiye. [PDF]
Durusu Tanrıöver M +9 more
europepmc +1 more source
The resilience of vaccine serotypes in adult invasive pneumococcal disease in Portugal, 2018-2023. [PDF]
Guerreiro-Nunes A +5 more
europepmc +1 more source
Invasive Pneumococcal Disease Epidemiology and Conjugate Vaccines in Canada, 2000-2019.
Ramos B +7 more
europepmc +1 more source
Invasive pneumococcal disease caused by vaccine serotype 9V in previously immunized adults. [PDF]
Deviaene M +3 more
europepmc +1 more source
Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain. [PDF]
Llorente J +8 more
europepmc +1 more source
Association between seasonal respiratory virus activity and invasive pneumococcal disease in central Ontario, Canada. [PDF]
Simmons AE +4 more
europepmc +1 more source
Allele-specific zinc metalloprotease B influences cardiac damage during invasive pneumococcal disease. [PDF]
Luck JN +12 more
europepmc +1 more source
Epidemiological and clinical impact of pneumococcal disease in Spain in 2023: A nationwide retrospective analysis. [PDF]
Garcia-Carretero R +3 more
europepmc +1 more source

